COVID-19 Testing for Schools
Accessible PCR COVID-19 Testing Solutions Support Schools and Peace of Mind
Scalable Gold-Standard PCR COVID-19 Testing for Schools
Partner with American Molecular Laboratories Today
Scalable Solutions
Our labs are capable of processing up to 20,000 PCR tests per day and are available for in both low and high-volume batches.
Ready When You Are
Our labs are open 7 days a week and are capable of handling your school’s COVID-19 testing needs.

Fewer Classroom Disruptions
We guarantee a 24-hour turnaround time with many results returning in as little as 3 hours so your students and staff can return to the classroom as soon as possible.
Easy to Use
With our web and mobile app created for school administrators, you can monitor compliance and track, trace, and report instantly from your computer saving you time and ensuring peace of mind when handling the many concerns of students, parents, and teachers.
Partner with American Molecular Laboratories Today
American Molecular Laboratories and Testing Services FAQ
Yes, our lab is both CLIA certified and CAP accredited.
Yes, it is able to seamlessly integrate with other healthcare infrastructure LIMS and EMRs.
No minimum testing volume is required.
Our tests include the gold standard RT-PCR test for COVID-19 detection, COVID-19 RNA sequencing for variants/mutations, and COVID-19 antibody test.
Yes, we provide COVID-19 swab and saliva collection kits free to our clients.
As fast as 3 hours, average turnaround time 6 hours, and guaranteed within 24 hours.
Normally between 3-5 business days.
Our COVID-19 RT-PCR tests start as low as $15 per test based on the volume.
Our COVID-19 RT-PCR test is able to detect all of the COVID-19 viruses with variances including Delta, but does not differentiate the variants. Our COVID-19 sequencing assay can differentiate and report all of the variants.
We accept Nasopharyngeal swabs samples for our respiratory COVID/Flu panel.
American Molecular Laboratories is validating the reliable/accurate ELISA assays to test COVID-19 antibodies.